Leroy
Avastin received accelerated FDA approval in 2008 for the treatment of breast cancer but now the FDA says studies have shown that Avastin is not effective and they are considering a plan to withdraw approval for the drug to treat breast cancer.
With the 2008 accelerated approval the FDA signaled an important new life saving drug was available. Did they really get it wrong then? We assume back in 2008 the FDA reviewed studies that showed the drugs effectiveness? What is the difference between those 2008 studies and the ones they say now show the drug is ineffective when used to treat breast cancer? The public deserve a detailed explanation!
Some breast cancer patients are outraged over the possible withdrawal. Who can blame them?